Related Experiment Video

Updated: May 28, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Molecular epidemiology of hepatitis B virus

Jia-Horng Kao1

  • 1Department of Internal Medicine, Graduate Institute of Clinical Medicine, Hepatitis Research Center, and Department of Medical Research, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. kaojh@ntu.edu.tw

The Korean Journal of Internal Medicine
|October 22, 2011
PubMed

Insights

Hepatitis B virus (HBV) genotypes significantly impact disease progression and treatment outcomes. Identifying HBV genotypes helps predict patient risk and optimize antiviral therapies for chronic hepatitis B.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Hepatitis B virus (HBV) infection remains a major global health concern, causing chronic hepatitis, cirrhosis, and liver cancer.
  • Despite available vaccines, HBV causes over 600,000 deaths annually worldwide.
  • HBV's lack of proofreading in its reverse transcriptase leads to diverse genotypes, subgenotypes, mutants, and recombinants.

Purpose of the Study:

  • To investigate the clinical significance of HBV genotypes in disease progression and treatment response.
  • To highlight the importance of HBV genotyping for personalized patient management.

Main Methods:

  • Identification and classification of at least 10 distinct HBV genotypes (A-J) based on genomic sequence divergence (>8%).
  • Analysis of the correlation between specific HBV genotypes and the risk of developing cirrhosis and hepatocellular carcinoma.
  • Evaluation of treatment responses to interferon and nucleos(t)ide analogues across different HBV genotypes.

Main Results:

  • HBV genotypes C and D are associated with a higher risk of cirrhosis and hepatocellular carcinoma compared to genotypes A and B.
  • Patients with HBV genotypes A and B show a more favorable response to interferon therapy (hepatitis B e antigen seroconversion).
  • Therapeutic efficacy of nucleos(t)ide analogues is generally consistent across different HBV genotypes.

Conclusions:

  • HBV genotyping is crucial for identifying patients at higher risk of severe liver disease.
  • Genotype-specific risk assessment enables physicians to tailor and optimize antiviral treatment strategies for chronic hepatitis B.
  • Understanding HBV genotypes improves clinical outcomes and disease management.

Keywords:
Antiviral agentsGenotypeHepatitis B virusHepatocellular carcinomaMolecular epidemiology

More Related Videos

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...